Nichiban Co., Ltd.

Nichiban Co., Ltd.

NHBAF
Nichiban Co., Ltd.US flagOther OTC
12.70
USD
- -
- -
258.54MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1,857.65
1,940.85
1,924.8
2,048.8
2,130.18
2,231.18
2,288.31
2,126.46
1,995.05
2,081.64
2,203.2
2,282.68
2,430.18
1,201.73
Basic EPS, GAAP
47.67
47.72
63.26
88.15
149.93
151.15
154.09
84.5
65.15
87.3
114.66
89
96.26
68.7
Free Cash Flow per Basic Share
10.57
45.55
26.97
118.17
-76.77
-88.75
37.69
207.9
155.78
45.27
1.06
-28.11
113.36
- -
Dividend per Share
12.01
11.97
12.01
15.97
21.96
35.95
39.91
37.93
33.01
29.97
30.08
35.12
34.94
- -
Book Value per Share
996.57
1,032.35
1,067.39
1,139.6
1,267.64
1,382.89
1,497.05
1,543.58
1,575.77
1,632.53
1,720.49
1,787.01
1,863.83
1,811.44
Tangible Book Value per Share
1,184.93
1,222.65
1,289.87
1,344.38
1,469.63
1,593.54
1,744.38
1,773.2
1,791.5
1,818.91
1,903.81
1,983.48
2,090.2
2,021.34
Basic Weighted Avg Shares
21
21
21
21
21
21
21
21
21
21
21
21
20
20
Sales/Revenue/Turnover
38,502
40,225
39,892
42,461
44,145
46,234
47,417
44,063
41,340
43,134
45,560
46,859
49,457
24,401
Operating Margin (%)
4.62
4.45
5.42
7.92
9.19
9.56
7.77
6.75
4.84
5.68
3.53
4.42
5.23
6.33
Depreciation Expense
1,741
1,787
1,385
1,603
1,792
1,960
2,327
2,352
2,342
2,545
2,757
2,795
3,145
- -
Net Income, GAAP
988
989
1,311
1,827
3,107
3,132
3,193
1,751
1,350
1,809
2,371
1,827
1,959
1,395
Effective Tax Rate (%)
38.21
43.2
39.62
34.27
26.4
28.62
29.85
29.55
28.95
29.32
30.87
19.58
25.42
14.67
Profit Margin (%)
2.57
2.46
3.29
4.3
7.04
6.77
6.73
3.97
3.27
4.19
5.2
3.9
3.96
5.72
Working Capital
16,608
17,227
17,751
18,160
16,050
13,730
14,968
19,246
19,575
19,543
20,095
21,759
22,716
22,670
LT Debt
2,502
2,507
2,438
2,326
2,251
2,170
137
2,104
2,069
2,094
2,090
2,082
2,080
2,000
Total Equity
24,791
25,547
26,884
28,138
30,764
33,315
36,479
37,216
38,076
38,959
40,602
41,702
43,186
41,847
Return on Invested Capital (%)
4.01
3.59
4.45
7.14
9.1
8.97
6.81
5.31
3.54
4.17
2.59
3.82
4.29
3.03
Return on Capital (%)
4.42
4.26
5.46
7.25
11.39
10.57
10.01
5.26
3.97
5.12
6.45
4.85
5.04
3.71
Return on Common Equity (%)
4.87
4.7
6.03
7.99
12.46
11.4
10.7
5.56
4.18
5.44
6.83
5.06
5.25
3.87

Capital Structure

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
52
- -
- -
LT Borrowings
2,000
- -
2,000
LT Finance Leases
82
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
20
- -
20
Market Capitalization
39,644
41,512
37,067

Working Capital

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
38,639
- -
38,335
Cash, Cash Equivalents & STI
13,405
- -
14,016
Accounts Receivable, Net
9,649
- -
8,685
Inventories
9,277
- -
9,626
Total Current Liabilities
16,880
- -
15,665
Payables & Accruals
- -
- -
- -
ST Debt
52
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.89%
3.02%
3.56%
Free Cash Flow
-291.84%
-683.24%
-499.83%
Net Income, GAAP
9.35%
5.29%
7.22%
Sales/Revenue/Turnover
2.28%
2.43%
5.54%
Total Cash Common Dividend
13.27%
-1.5%
-1.39%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
10,916
11,542
13,046
11,355
46,859
2025
- -
- -
- -
- -
49,457
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
13.63
- -
- -
- -
89
2025
- -
- -
- -
- -
96.26
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
35.12
2025
- -
- -
- -
- -
34.94
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Toshiaki Takatsu
Full Time Employees
1,270
Sector
Industrials
Industry
Business Equipment & Supplies
Address
2-3-3, Sekiguchi Tokyo Japan 112-8663
IPO Date
Dec 7, 2020
Business
Nichiban Co., Ltd. engages in the development, manufacture, and sale of medical products, adhesive tapes, adhesives, and related equipment, operating primarily in the medical and tape business segments. The company offers a broad portfolio including medical products such as surgical tapes, wound care dressing tapes, post-operative care tapes, cornea protection tapes, hemostatic and first-aid bandages, kinesiology tapes, pain relief creams, and foot care products. It also produces industrial tapes used in packaging, carton boxes, agriculture, vehicles, construction, home appliances, electronic materials, and machinery applications. Additionally, Nichiban provides stationery and office products including cellulose adhesive tapes, double-sided tapes, adhesive transfer tapes, bookbinding tapes, and other adhesive-related products. Founded in 1918 and headquartered in Tokyo, Japan, Nichiban serves markets in Asia, Europe, and internationally with a workforce of approximately 1,271 consolidated employees. Recent developments include continued expansion of its product lines and strategic emphasis on adhesive technologies across healthcare, industrial, and office sectors, alongside stable financial performance with a forecasted 16% increase in operating profit for fiscal 2026, reflecting growth optimism despite recent modest sales increases and profit fluctuations. The company maintains a strong equity-to-asset ratio and has reinforced its market presence through sustained innovation in adhesive materials and medical tapes. Nichiban continues to leverage its adhesive technology expertise to contribute to health, comfortable living, business environments, and industrial advancement globally.